Kenji Suzuki, Y. Sameshima, J. Yokoyama, Shuji Terai, Hiroyuki Yoneyama, R. Atreya, M. F. Neurath, Toshifumi Hibi, Hitoshi Asakura
{"title":"中度至重度溃疡性结肠炎患者在接受抗肿瘤坏死因子抗体治疗的同时多次黏膜下注射 RNA 寡核苷酸 GUT-1:一项开放标签的概念验证研究","authors":"Kenji Suzuki, Y. Sameshima, J. Yokoyama, Shuji Terai, Hiroyuki Yoneyama, R. Atreya, M. F. Neurath, Toshifumi Hibi, Hitoshi Asakura","doi":"10.1186/s41232-024-00332-7","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":94041,"journal":{"name":"Inflammation and regeneration","volume":"82 6","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Add-on multiple submucosal injections of the RNA oligonucleotide GUT-1 to anti-TNF antibody treatment in patients with moderate-to-severe ulcerative colitis: an open-label, proof-of concept study\",\"authors\":\"Kenji Suzuki, Y. Sameshima, J. Yokoyama, Shuji Terai, Hiroyuki Yoneyama, R. Atreya, M. F. Neurath, Toshifumi Hibi, Hitoshi Asakura\",\"doi\":\"10.1186/s41232-024-00332-7\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":94041,\"journal\":{\"name\":\"Inflammation and regeneration\",\"volume\":\"82 6\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Inflammation and regeneration\",\"FirstCategoryId\":\"0\",\"ListUrlMain\":\"https://doi.org/10.1186/s41232-024-00332-7\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Inflammation and regeneration","FirstCategoryId":"0","ListUrlMain":"https://doi.org/10.1186/s41232-024-00332-7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Add-on multiple submucosal injections of the RNA oligonucleotide GUT-1 to anti-TNF antibody treatment in patients with moderate-to-severe ulcerative colitis: an open-label, proof-of concept study